The notices it replaced
- Reissues: PAR-21-251 Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- 2 steps back: PAR-19-051 Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- 3 steps back: PAR-17-001 Emerging Global Leader Award (K43)
- 4 steps back: PAR-15-292 Emerging Global Leader Award (K43)
Who won it before
67 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,431,596 in first-year total cost, median $96,519.
Most frequent study sections
- International and Cooperative Projects - 1 Study Section[ICP1]42
- Special Emphasis Panel[ZRG1 ICP-P (55)]12
- Special Emphasis Panel[ZRG1 BDA-A (90)]4
- Special Emphasis Panel[ZRG1 BDCN-S (02)]3
- Special Emphasis Panel[ZRG1 ICP-J (55)]3
Most frequent institutions
- MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY6
- UNIVERSITY OF CAPE TOWN6
- COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN5
- INFECTIOUS DISEASES INSTITUTE4
- HANOI MEDICAL UNIVERSITY3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Enhancing adherence and completion of the three-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy regimen through biomarker-guided adherence counselling1K43TW013135-01 | ONYANGO, DICKENS OTIENO | KENYATTA NATIONAL HOSPITAL | $169,015 | ZRG1 |
| 2025 | Implementing screening and brief intervention for substance use in primary care in rural Georgia1K43TW013136-01 | NADAREISHVILI, ILIA | DAVID TVILDIANI MEDICAL UNIVERSITY LLC | $117,705 | ZRG1 |
| 2025 | Clinical risk calculator validation and implementation to optimize prostate cancer early detection in Nigeria1K43TW013133-01 | TOLANI, MUSLIU ADETOLA | AHMADU BELLO UNIVERSITY | $103,950 | ZRG1 |
| 2025 | Integrating Cutting-Edge Whole Person HIV and Substance Use Care in Vietnam and Beyond1K43TW013176-01 | NGUYEN, DIEP BICH | HANOI MEDICAL UNIVERSITY | $73,847 | ZRG1 |
| 2024 | Integration of Mental Health Services in HIV Care for Adolescents and Youth in Kenya1K43TW012632-01A1 · under PAR-21-251 | WACHIRA, CYRUS MUGO | KENYATTA NATIONAL HOSPITAL | $133,330 | ZRG1 |
| 2024 | Developing a suicide prevention intervention for people with HIV in South Africa1K43TW012840-01 · under PAR-21-251 | RABIE, STEPHAN | UNIVERSITY OF CAPE TOWN | $113,240 | ZRG1 |
| 2024 | Integrating tuberculosis treatment into community pharmacies to improve TB/HIV outcomes in Uganda.1K43TW012839-01 · under PAR-21-251 | IZUDI, JONATHAN | INFECTIOUS DISEASES INSTITUTE | $109,704 | ZRG1 |
| 2024 | Informing optimal dosing of the future antimalarial, artemether-lumefantrine plus amodiaquine, in key neglected target populations of children with severe acute malnutrition and adults living with HIV1K43TW012801-01 · under PAR-21-251 | BANDA, CLIFFORD GEORGE | KAMUZU UNIVERSITY OF HEALTH SCIENCES | $108,916 | ZRG1 |
| 2024 | Improving Diagnostic Strategies for Post-Tuberculosis Lung Disease in Ugandan Primary Healthcare Settings1K43TW012781-01 · under PAR-21-251 | NUWAGIRA, EDWIN | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $108,237 | ZRG1 |
| 2024 | Development and evaluation of a physical activity intervention for obese people with HIV in rural South Africa.1K43TW012862-01 · under PAR-21-251 | MABWEAZARA, SMART | KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV | $95,530 | ZRG1 |
| 2024 | Friendship Bench for Women Who Use Methamphetamine in Vietnam1K43TW012620-01A1 · under PAR-21-251 | NGUYEN, TRANG | HANOI MEDICAL UNIVERSITY | $70,179 | ZRG1 |
| 2024 | Adapting an evidence-based intervention to improve HIV testing and PrEP uptake among young men who have sex with men in Vietnam1K43TW012850-01 · under PAR-21-251 | NGUYEN, MINH XUAN BINH | HANOI MEDICAL UNIVERSITY | $66,427 | ZRG1 |
| 2023 | Peer delivered HIV/syphilis self-testing with assisted partner notification services for men who have sex with men (MSM) in Uganda1K43TW012637-01 · under PAR-21-251 | OKOBOI, STEPHEN | INFECTIOUS DISEASES INSTITUTE | $109,911 | ZRG1 |
| 2023 | A social media mHealth intervention to improve retention in care for adolescents and young adults with HIV in Uganda1K43TW012640-01 · under PAR-21-251 | ADONG, JULIAN | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $100,402 | ZRG1 |
| 2023 | Multidisciplinary sickle cell disease obstetrics care program in Ghana: Non-academic vs.Academic Hospital (Pilot Study)1K43TW012579-01 · under PAR-21-251 | ASARE, EUGENIA VICKY | COLLEGE OF HEALTH SCIENCES, UNIVERSITY OF GHANA | $85,310 | ZRG1 |
| 2022 | Cultural Adaptation of a Web-Based App (myPlan Thailand) to Empower and Support Friends and Family of Intimate Partner Violence Survivors1K43TW012296-01 · under PAR-21-251 | UDMUANGPIA, TIPPARAT | BOROMARAJONANI COLLEGE OF NURSING KHON KAEN | $95,992 | ZRG1 |
| 2022 | Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria1K43TW011995-01A1 · under PAR-21-251 | ADEDEJI, WAHEED ADEOLA | COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN | $69,460 | ZRG1 |
| 2021 | Self-Management among adolescents living with HIV in Uganda1K43TW011929-01 · under PAR-19-051 | ASHABA, SCHOLASTIC | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $108,335 | ICP1 |
| 2021 | A community intervention to promote evidence-based mental health care for olderadults with depressive and anxiety symptoms.1K43TW011586-01A1 · under PAR-19-051 | FLORES-FLORES, OSCAR GUILLERMO | UNIVERSIDAD DE SAN MARTIN DE PORRES | $107,177 | ICP1 |
| 2021 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa1K43TW011943-01 · under PAR-19-051 | PHILLIPS, TAMSIN KATE | UNIVERSITY OF CAPE TOWN | $93,129 | ZRG1 |
| 2020 | A mobile phone short message service intervention to increase retention in HIV care among HIV-positive men who have sex with men in Peru (WelTel Peru)1K43TW011428-01A1 · under PAR-19-051 | MENACHO ALVIRIO, LUIS ALBERTO | UNIVERSIDAD PERUANA CAYETANO HEREDIA | $149,973 | ICP1 |
| 2020 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis.1K43TW011006-01A1 · under PAR-17-001 | DU PREEZ, KAREN | STELLENBOSCH UNIVERSITY | $100,603 | ICP1 |
| 2020 | Primary Prevention of Stroke in Children with Sickle Cell Anaemia in Nigeria: Community vs Teaching Hospital1K43TW011583-01 · under PAR-19-051 | BELLO-MANGA, HALIMA | BARAU DIKKO TEACHING HOSPITAL/ KADUNA STATE UNIVERSITY | $85,050 | ZRG1 |
| 2020 | Effect of Community Wide Deworming on Hookworm Modulated Immune Responses to Bystander Antigens and Vaccines in Southern India1K43TW011415-01 · under PAR-17-001 | AJJAMPUR, SITARA SWARNA RAO | CHRISTIAN MEDICAL COLLEGE | $64,800 | ZRG1 |
| 2019 | Psychosocial distress, inflammatory reactivity and central sensitization in the pathway to HIV-related pain: characterizing the associations and developing a pragmatic, coping-focused intervention.1K43TW011442-01 · under PAR-19-051 | MADDEN, VICTORIA JOY | UNIVERSITY OF CAPE TOWN | $109,633 | ICP1 |
| 2019 | Dolutegravir for the treatment of HIV in patients with Tuberculosis in KwaZulu-Natal South Africa1K43TW011437-01 · under PAR-17-001 | NAIDOO, ANUSHKA | CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA | $102,834 | ICP1 |
| 2019 | Responding to the challenges of Adolescent Perinatal Depression with patient-centered mobile health1K43TW011046-01A1 · under PAR-17-001 | KOLA, LOLA | COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN | $99,857 | ICP1 |
| 2019 | Oxygen sensing mechanism(s) in fetal programming of salt-sensitive hypertension1K43TW011009-01A1 · under PAR-17-001 | OLOYO, AHMED KOLADE | COLLEGE OF MEDICINE, UNIVERSITY OF LAGOS | $96,056 | ICP1 |
| 2019 | Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis1K43TW011421-01 · under PAR-19-051 | WASSERMAN, SEAN ADAM | UNIVERSITY OF CAPE TOWN | $93,850 | ZRG1 |
| 2019 | Vaginal Microbiome in Cervical Intraepithelial Neoplasia and Cancer1K43TW011416-01 · under PAR-17-001 | MUSA, JONAH | UNIVERSITY OF JOS | $92,988 | ZRG1 |
| 2019 | "Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"1K43TW011418-01 · under PAR-17-001 | LIDENGE, SALUM JUMA | MUHIMBILI UNIVERSITY/ ALLIED HLTH SCIS | $92,175 | ZRG1 |
| 2019 | Elucidating Cleft Etiology Employing Multiplex and Twin Families (ElCEEMuTF)1K43DE029427-01 · under PAR-17-001 | GOWANS, LORD JEPHTHAH JOOJO | KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH | $91,253 | ICP1 |
| 2019 | The role of HbF decline and its determinants on Sickle Cell Disease expression in the first three years of life.1K43TW011167-01A1 · under PAR-17-001 | NKYA, SIANA WATOKY | MUHIMBILI UNIVERSITY/ ALLIED HLTH SCIS | $88,940 | ICP1 |
| 2019 | The Role of Sex Steroid Hormones in CD4+ T Cell-mediated Immune Responses to Tuberculosis1K43TW011426-01 · under PAR-17-001 | DABITAO, DJENEBA | UNIV OF SCIENCES, TECH & TECH OF BAMAKO | $85,664 | ZRG1 |
| 2019 | Defining Campylobacter and immune response related determinants in the pathogenesis of Guillain-Barré syndrome patients in low-income countries1K43TW011447-01 · under PAR-17-001 | ISLAM, ZHAHIRUL | INTERNATIONAL CTR/DIARRHOEAL DIS RES | $85,249 | ICP1 |
| 2019 | Undetectable and Untransmittable: reducing HIV transmission among young women living with HIV, their partners and children in South Africa1K43TW011434-01 · under PAR-17-001 | TOSKA, ELONA | UNIVERSITY OF CAPE TOWN | $85,034 | ICP1 |
| 2019 | Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India1K43TW011164-01 · under PAR-17-001 | SINGH, KAVITA | PUBLIC HEALTH FOUNDATION OF INDIA | $69,249 | ICP1 |
| 2019 | Host defense against Shigella flexneri1K43TW011441-01 · under PAR-17-001 | NOOR, ZANNATUN | INTERNATIONAL CTR/DIARRHOEAL DIS RES | $61,227 | ZRG1 |
| 2018 | Patient-centered intervention to prevent tuberculosis among children < 5 years old1K43TW011137-01 · under PAR-17-001 | OTERO, LARISSA | UNIVERSIDAD PERUANA CAYETANO HEREDIA | $128,325 | ICP1 |
| 2018 | IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)1K43TW011178-01 · under PAR-17-001 | PETER, JONATHAN | UNIVERSITY OF CAPE TOWN LUNG INSTITUTE | $113,400 | ICP1 |
| 2018 | Feasibility and acceptability of Enhanced Patient Care (EPC) for adult HIV patients with unsuppressed viral loads in western Kenya1K43TW010684-01A1 · under PAR-17-001 | WACHIRA, JUDDY | MOI UNIVERSITY COLLEGE OF HEALTH SCIENCES | $110,642 | ICP1 |
| 2018 | Patient-centered mobile technology interventions to improve maternal health in Uganda1K43TW011004-01 · under PAR-17-001 | ATUKUNDA, ESTHER CATHYLN | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $108,567 | ICP1 |
| 2018 | Investigation of responses to Mycobacterium tuberculosis complex lineages by different African host population: Implications for host-directed therapies1K43TW011125-01 · under PAR-17-001 | TIENTCHEU DJOMKAM, LEOPOLD | MEDICAL RESEARCH COUNCIL UNIT THE GAMBIA AT THE LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE | $106,087 | ICP1 |
| 2018 | Implementing mental health interventions for pregnant adolescents in primary care LMIC contexts1K43TW010716-01A1 · under PAR-17-001 | KUMAR, MANASI | UNIVERSITY OF NAIROBI | $102,600 | ICP1 |
| 2018 | Changing the Culture of Disrespect and Abuse in Maternity Care in Kumasi, Ghana1K43TW011022-01 · under PAR-17-001 | DZOMEKU, VERONICA MILLICENT | KWAME NKRUMAH UNIVERSITY/SCIENCE/TECH | $86,584 | ICP1 |
| 2018 | Biomarkers of Kaposi sarcoma recrudescence in Zambia1K43TW011095-01 · under PAR-17-001 | NGALAMIKA, OWEN | UNIVERSITY OF ZAMBIA | $80,029 | ICP1 |
| 2018 | Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)1K43TW010721-01A1 · under PAR-17-001 | NTEKIM, ATARA ISAIAH | COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN | $74,125 | ICP1 |
| 2018 | APOL1 and increased risk of Preeclampsia in West Africa1K43TW011160-01 · under PAR-17-001 | OSAFO, CHARLOTTE | COLLEGE OF HEALTH SCIENCES, UNIVERSITY OF GHANA | $68,167 | ICP1 |
| 2017 | Developing a care bundle for neonatal sepsis prevention in low-resource settings1K43TW010682-01 · under PAR-17-001 | DRAMOWSKI, ANGELA | STELLENBOSCH UNIVERSITY | $113,400 | ICP1 |
| 2017 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa1K43TW010683-01 · under PAR-17-001 | SLOGROVE, AMY LOUISE | STELLENBOSCH UNIVERSITY | $112,530 | ICP1 |
| 2017 | HIV Self Testing to Empower Prevention Choices in Sex Workers1K43TW010695-01 · under PAR-17-001 | MUJUGIRA, ANDREW | INFECTIOUS DISEASES INSTITUTE | $108,863 | ICP1 |
| 2017 | Endocrine and metabolic diseases in rural South Africa-establishing burden and improving detection1K43TW010698-01 · under PAR-17-001 | WADE, ALISHA NICOLE | WITS HEALTH CONSORTIUM (PTY), LTD | $105,314 | ICP1 |
| 2017 | Impact of malaria control interventions on the infectious reservoir, host immunity, and drug resistance in Uganda1K43TW010365-01A1 · under PAR-17-001 | NANKABIRWA, JOANITER IMMACULATE | INFECTIOUS DISEASES RES COLLABORATION | $102,911 | ICP1 |
| 2017 | Epidemiology, Immunopathogenesis, and Outcomes of Non-traumatic Spinal Cord Injury in Uganda1K43TW010718-01 · under PAR-17-001 | MUSUBIRE, ABDU KISEKKA | INFECTIOUS DISEASES INSTITUTE | $98,622 | ICP1 |
| 2017 | Seizure frequency, Quality of Life and stigma reduction in people living with epilepsy1K43TW010401-01A1 · under PAR-17-001 | KADDUMUKASA, MARK | MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES | $96,552 | ICP1 |
| 2017 | Promoting Physical Activity and Healthy Eating Among Adults in a Faith-Based Setting In Lagos, Nigeria.1K43TW010704-01 · under PAR-17-001 | ODUKOYA, OLUWAKEMI | COLLEGE OF MEDICINE, UNIVERSITY OF LAGOS | $96,477 | ICP1 |
| 2017 | Polycyclic aromatic hydrocarbons exposure and dietary risk of Esophageal squamous cell carcinoma in Uganda1K43TW010715-01 · under PAR-17-001 | OKELLO, SAMSON | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $90,570 | ICP1 |
| 2017 | Genetic Testing for Accurate Diabetes Differentiation in Nigeria1K43TW010720-01 · under PAR-17-001 | BALOGUN, WILLIAMS ONABUMEH | COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN | $72,495 | ICP1 |
| 2017 | Development of Nanomedicines for Tuberculosis Treatment1K43TW010371-01A1 · under PAR-17-001 | DUBE, ADMIRE | UNIVERSITY OF THE WESTERN CAPE | $69,798 | ICP1 |
| 2017 | Microbiota, Inflammation and Environmental Enteric Dysfunction (MiEED)1K43TW010697-01 · under PAR-17-001 | IQBAL, NAJEEHA TALAT | AGA KHAN UNIVERSITY (PAKISTAN) | $57,663 | ICP1 |
| 2016 | Gestational diabetes mellitus, gestational hypertension and risk of metabolic syndrome1K43TW010363-01 · under PAR-15-292 | OSOTI, ALFRED ONYANGO | UNIVERSITY OF NAIROBI | $113,240 | ICP1 |
| 2016 | Safety and Cognition in Driving (SCID): A proposal to examine functional driving skills in professional drivers in Cape Town.1K43TW010361-01 · under PAR-15-292 | GOUSE, HETTA-MARI | UNIVERSITY OF CAPE TOWN | $111,608 | ICP1 |
| 2016 | Real time Tuberculosis Medication Adherence Intervention in Rural Southwestern Uganda1K43TW010388-01 · under PAR-15-292 | MUSIIMENTA, ANGELLA | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY | $98,717 | ICP1 |
| 2016 | Rotavirus vaccination in South Africa: safety and factors influencing the immune response to oral enteric vaccine1K43TW010382-01 · under PAR-15-292 | GROOME, MICHELLE JENNIFER | WITS HEALTH CONSORTIUM (PTY), LTD | $96,519 | ICP1 |
| 2016 | Pilot evaluation of a telephone-based psychosocial intervention package for perinatal depression in Nigeria1K43TW010400-01 · under PAR-15-292 | OLADEJI, BIBILOLA DAMILOLA | COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN | $71,915 | ICP1 |
| 2016 | Humoral and adaptive immune responses study in Vibrio cholerae infection1K43TW010362-01 · under PAR-15-292 | BHUIYAN, MD TAUFIQUR RAHMAN | INTERNATIONAL CTR/DIARRHOEAL DIS RES | $71,661 | ICP1 |
| 2016 | Addressing barriers to Scaling-up Perinatal Mental Health Intervention1K43TW010399-01 · under PAR-15-292 | SIKANDER, SIHAM | HUMAN DEVELOPMENT RESEARCH FOUNDATION | $69,984 | ICP1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.